Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

9.550 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Earnings Preview: Prothena Corp ↗
Prothena Corp (NASDAQ:PRTA) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Prothena Corp... 
Via Benzinga
News headline image
As Small Caps Rally, These 3 Finance High-Yielders Could Have Further Upside ↗
In the past month with the Russell 2000 index up roughly 7%, as compared to the S&P 500 index up nearly 4.8%, it is evident that small cap stocks are leading the charge in this bear market rally. The... 
Via Benzinga
News headline image
Prothena to Report Third Quarter 2022 Financial Results on November 3rd
From Prothena Corporation plc
Via GlobeNewswire
Alzheimer’s Pipeline of New Treatments Race to Improve Quality of Life for Patients
Palm Beach, FL – October 20, 2022 – FinancialNewsMedia.com News Commentary – Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, (AD) which... 
Via FinancialNewsMedia
News headline image
Recap: Prothena Corp Q2 Earnings ↗
  Prothena Corp (NASDAQ:PRTA) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
Via Benzinga
News headline image
Netflix, Biogen And Other Big Gainers From Wednesday ↗
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs ↗
Prothena Corporation plc (NASDAQ: PRTA)  
Via Benzinga
News headline image
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
LVWR Stock Alert: 7 Things to Know as LiveWire Starts Trading ↗
LiveWire (LVWR) stock is in the news Wednesday as the electric motorcycle company makes its trading debut today after a SPAC merger. 
Via InvestorPlace
News headline image
Why Is Prothena (PRTA) Stock Up 75% Today? ↗
Prothena (PRTA) stock is seeing massive gains on Wednesday despite a lack of recent news from the late-stage clinical company. 
Via InvestorPlace
News headline image
Stocks Take Another Stab At Rebound As Bond Yields Soften ↗
Stocks are making another attempt to rebound on Wednesday, with the Dow Jones Industrial Average and S&P 500 Index both up roughly 1% at the midway mark. 
Via Talk Markets
News headline image
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
How Is The Market Feeling About Prothena Corp? ↗
Prothena Corp's (NASDAQ:PRTA) short percent of float has fallen 8.23% since its last report. The company recently reported that it has 2.46 million shares sold short, which is 13.83% of all regular... 
Via Benzinga
News headline image
US Stocks Mixed; Wholesale Inventories Increase 1.3% In August ↗
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022 ↗
Upgrades 
Via Benzinga
News headline image
What's Going On With Prothena Stock Up Over 60% Today ↗
Prothena Corporation PLC (NASDAQ: PRTA) shares are trading higher by 61.27% to $49.88 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning. 
Via InvestorPlace
News headline image
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday. 
Via Benzinga
News headline image
Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session. 
Via Benzinga
News headline image
Prothena Corp's Return On Capital Employed Overview ↗
Prothena Corp (NASDAQ:PRTA) brought in sales totaling $1.31 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 13.65%, resulting in a loss of $41.24 million. 
Via Benzinga
News headline image
Jim Cramer Says This Company Is A Great One ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Woodside Energy Group Ltd (NYSE: WDS) is a great company, with a great yield. 
Via Benzinga
News headline image
Earnings Scheduled For August 8, 2022 ↗
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. 
Via Benzinga
News headline image
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
A Preview Of Prothena Corp's Earnings ↗
Prothena Corp (NASDAQ:PRTA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Prothena Corp... 
Via Benzinga
News headline image
Why RBC Capital Sees 'Multiple High-Risk' On This Neurology-Focused Stock ↗
RBC Capital Markets writes that Prothena Corporation plc (NASDAQ: PRTA) believes that the recent stock downside provides an entry point and that progress with the programs and improved sentiment in the... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
Morgan Stanley boosted Archer-Daniels-Midland Company (NYSE: ADM) price target from $69 to $94. Archer-Daniels-Midland shares fell 0.5% to $89.10 in pre-market trading. 
Via Benzinga
News headline image
Prothena Receives FDA Fast Track Designation for PRX012 for the Treatment of Alzheimer's Disease ↗
Prothena Corporation plc (NASDAQ: PRTA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-amyloid beta (Aβ) antibody therapy drug candidate... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.